# Boehringer Ingelheim Fremont, Inc. – FDA Inspection, Aug 24, 2018

Source: https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-fremont-inc/fe8b0eff-9aee-4c03-a4e1-cee8ba3aae35
Source feed: FDA_Inspections

> FDA inspection 1063730 of Boehringer Ingelheim Fremont, Inc., August 24, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1063730
- Company Name: Boehringer Ingelheim Fremont, Inc.
- Inspection Date: 2018-08-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1263388 - 2024-05-16](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-fremont-inc/ce7fd041-d5df-4734-84bf-8c8491fceee4)
- FDA Inspection 1205076 - 2023-04-13
- [FDA Inspection 1187410 - 2022-11-04](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-fremont-inc/817f2419-ae3e-4fdf-b387-b7551f09fb7e)
- [FDA Inspection 1005958 - 2017-04-04](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-fremont-inc/ff7cd87f-90a8-4b66-8652-6004f0512e9e)
- FDA Inspection 882791 - 2014-05-28

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/anita-narula/fbebf5a2-e25c-4e98-9c22-433d9102380c)
- [FDA Associated Person](https://www.keypedia.com/people/marcus-f-yambot/a2266014-ae7e-4d64-aeba-a8cfb873f100)

Company: https://www.keypedia.com/companies/boehringer-ingelheim-fremont-inc/3d7d0ca7-27cd-4223-8ade-7193417c9861

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c